Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background & Aims</h3><p>Nonalcoholic fatty liver disease (NAFLD), especially the nonalcoholic steatohepatitis (NASH), have become a major cause of liver transplantation and liver‐associated death. NASH is the hepatic manifestation of metabolic syndrome and is characterized by hepatic steatosis, inflammation, hepatocellular injury and different degrees of fibrosis. However, there is no FDA‐approved medication to treat this devastating disease. Therapeutic activators of the AMP‐Activated Protein Kinase (AMPK) have been proposed as a potential treatment for metabolic diseases such as NASH. Cordycepin, a natural product isolated from the traditional Chinese medicine <i>Cordyceps militaris</i>, has recently emerged as a promising drug candidate for metabolic diseases. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Approach & Results</h3><p>We evaluated the effects of cordycepin on lipid storage in hepatocytes, inflammation, and fibrosis development in mice with NASH. Cordycepin attenuated lipid accumulation, inflammation and lipotoxicity in hepatocytes subjected to metabolic stress. In addition, cordycepin treatment significantly and dose‐dependently decreased the elevated levels of serum aminotransferases in mice with diet‐induced NASH. Furthermore, cordycepin treatment significantly reduced hepatic triglyceride accumulation, inflammatory cell infiltration and hepatic fibrosis in mice. In vitro and in vivo mechanistic studies revealed that a key mechanism linking the protective effects of cordycepin were AMPK phosphorylation‐dependent, as indicated by the finding that treatment with the AMPK inhibitor Compound C abrogated cordycepin‐induced hepatoprotection in hepatocytes and mice with NASH.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Cordycepin exerts significant protective effects against hepatic steatosis, inflammation, liver injury, and fibrosis in mice under metabolic stress through activation of the AMPK signaling pathway. Cordycepin might be a novel AMPK activator that can be used for the treatment of NASH.</p></section>

Ameliorative Effect of Dietary Nucleotides on Liver Fibrosis in SAMP8 Mice

Anti-fibrosis Effects of Long-term Oral Administration of Dietary Nucleotides in the Chronologically Aging Liver of Sprague-dawley Male Rats

Dietary Nucleotides Supplementation And Liver Injury In Alcohol-Treated Rats: A Metabolomics Investigation

Dietary Nucleotides Protect Against Alcoholic Liver Injury by Attenuating Inflammation and Regulating Gut Microbiota in Rats.

NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice

[Effect of cannabinoid receptor-2 agonist AM1241 on platelet-derived growth factor expression in the liver tissue of mice with hepatic fibrosis]

Protective Effect of Nicotinamide on Acute Hepatic Failure in Mice

Anti-fatigue effects of dietary nucleotides in mice

EXOGENOUS 5'-NECLEOTIDES PROMOTE RESTORATION AFTER LIVER DAMAGE INDUCED BY ALCOHOL IN RATS

Dietary Nucleotides Alleviate Hepatic Lipid Deposition via Exogenous AMP-Mediated AMPK Activation in Zebrafish

Protective effect of dietary 5'-nucleotides on alcohol-induced kidney injury of mice

Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats

Naringenin ameliorates MASH fibrosis via regulating TAK1/MAPK/FoxO3a-mediated apoptosis in the activated hepatic stellate cells

Inorganic nitrate and nitrite ameliorate kidney fibrosis by restoring lipid metabolism via dual regulation of AMP-activated protein kinase and the AKT-PGC1α pathway

Study on the Hypolipidemic Effects of Dietary Nucleotides

The Effectiveness of Four Nicotinamide Adenine Dinucleotide (NAD+) Precursors in Alleviating the High-Glucose-Induced Damage to Hepatocytes in Megalobrama amblycephala: Evidence in NAD+ Homeostasis, Sirt1/3 Activation, Redox Defense, Inflammatory Response, Apoptosis, and Glucose Metabolism

[Effects of Soothing Liver and Invigorating Spleen Recipes on NF-kappaB Signal Pathway Related Genes and Proteins in Primary Hepatocytes of Rats with NASH].

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway

Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway

Alleviation of hepatic insulin resistance and steatosis with NMN via improving endoplasmic reticulum–Mitochondria miscommunication in the liver of HFD mice

NMN Supplementation Promotes Liver Growth-the Result of the Regulated Transcription and Metabolism